Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Bisphosphonate and Simvastatin Combination on Therapeutic Response in Breast Cancer With Bone Metastasis Via Dicckopf-1 Pathway : A Randomised, Double-blind, Placebo Controlled Pilot Trial

NCT07823751 is registered in ClinicalTrials.gov with Universitas Indonesia as lead sponsor.

NCT NCT07823751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07823751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Bisphosphonate and Simvastatin Combination on Therapeutic Response in Breast Cancer With Bone Metastasis Via Dicckopf-1 Pathway : A Randomised, Double-blind, Placebo Controlled Pilot Trial
Lead sponsor
Universitas Indonesia
Phase
Not applicable
Overall status
Completed
Start date
April 10, 2021
Completion date
June 20, 2026
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer with bone metastasis